BIOMERICA INC (BMRA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
BMRA currently has 2.64M outstanding shares. with minimal authorized share overhang for future dilution. The company has diluted shareholders by 24.43% over the past 2 years through share issuances. Recent corporate actions include 1 stock split (positive for accessibility).
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Oct 14, 2025 |
10-Q filing | 2.6M shares outstanding |
2.6M | 0 |
| Aug 29, 2025 |
10-K filing | 2.8M shares outstanding |
2.8M | 0 |
| Apr 21, 2025 |
Stock Split
8-K filing: Stock split one-for-eight | Outstanding: 19,186,282 → 2,545,762 |
2.5M | 0 |
| Apr 14, 2025 |
10-Q filing | 19.2M shares outstanding |
19M | 0 |
| Jan 14, 2025 |
10-Q filing | 17.1M shares outstanding |
17M | 0 |
| Oct 15, 2024 |
10-Q filing | 16.8M shares outstanding |
17M | 0 |
| Aug 28, 2024 |
10-K filing | 16.8M shares outstanding |
17M | 0 |
| Apr 12, 2024 |
10-Q filing | 16.8M shares outstanding |
17M | 0 |
| Jan 16, 2024 |
10-Q filing | 16.8M shares outstanding |
17M | 0 |
| Oct 12, 2023 |
10-Q filing | 16.8M shares outstanding |
17M | 0 |
| Sep 28, 2023 |
S-3 filing: Biomerica, Inc. may offer and sell shares of its common stock with total gross proceeds of up to $20,000,000 from time to time. |
16M | 0 |
| Aug 25, 2023 |
10-K filing | 16.8M shares outstanding |
17M | 0 |
| Apr 14, 2023 |
10-Q filing | 16.8M shares outstanding |
17M | 0 |
| Mar 07, 2023 |
8-K filing: Biomerica, Inc. completed a public offering of 3,333,333 shares of common stock at a price of $2.40 per share, resulting in net proceeds of approximately $7.4 million. ($8.0M proceeds) |
13M | 0 |
| Jan 13, 2023 |
10-Q filing | 13.5M shares outstanding |
13M | 0 |
| Oct 13, 2022 |
10-Q filing | 13.1M shares outstanding |
13M | 0 |
| Aug 29, 2022 |
10-K filing | 12.7M shares outstanding |
13M | 0 |
| Apr 14, 2022 |
10-Q filing | 12.8M shares outstanding |
13M | 0 |
| Jan 12, 2022 |
10-Q filing | 12.6M shares outstanding |
13M | 0 |
| Oct 14, 2021 |
10-Q filing | 12.4M shares outstanding |
12M | 0 |
| Aug 27, 2021 |
10-K filing | 11.9M shares outstanding |
12M | 0 |
| Apr 14, 2021 |
10-Q filing | 11.8M shares outstanding |
12M | 74K |
| Jan 14, 2021 |
10-Q filing | 11.8M shares outstanding |
12M | 120K |
| Oct 15, 2020 |
10-Q filing | 11.7M shares outstanding |
12M | 130K |
| Sep 11, 2020 |
S-3/A filing: Biomerica, Inc. files an S-3/A registration statement for a shelf offering of common stock, including a primary offering with total gross proceeds of up to $90,000,000 and a secondary offering of up to 571,429 shares of common stock by the selling stockholder. |
12M | 120K |
| Sep 02, 2020 |
8-K filing: Janet Moore will retire as CFO effective September 3, 2020, and Steve Sloan was appointed as CFO effective the same date. Cathy Coste was elected to the Board of Directors effective September 3, 2020. Mr. Sloan will receive an option grant of 50,000 shares of common stock, and Ms. Coste will receive an option grant of 25,000 shares of common stock. |
12M | 120K |
| Aug 31, 2020 |
10-K filing | 11.8M shares outstanding |
12M | 120K |
| Jul 21, 2020 |
S-3 filing: This is an S-3 filing for a shelf offering of common stock by Biomerica, Inc., including both a primary offering by the company and a secondary offering by a selling stockholder. |
12M | 120K |
| Apr 14, 2020 |
10-Q filing | 11.3M shares outstanding |
11M | 0 |
| Feb 27, 2020 |
8-K filing: Biomerica, Inc. completed the issuance and sale of 571,429 shares of Series A Convertible Preferred Stock to Palm Global Small Cap Master Fund LP for approximately $2 million, or $3.50 per share, on February 26, 2020. ($2.0M proceeds) |
9.8M | 0 |
| Jan 14, 2020 |
10-Q filing | 9.8M shares outstanding |
9.8M | 0 |